Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
JPGN Reports|November 17, 2025
Nutrition management of children with acute necrotizing pancreatitis following asparaginase: A case seriesJodie Greear, Lauren Steele, Hope D Swanson, et al.
Haematologica|February 13, 2025
Changes in asparaginase exposure and toxicity profiles in obese pediatric acute lymphoblastic leukemia patientsJohn C Panetta, Emily Ashcraft, Sima Jeha, et al.
Pediatric Blood & Cancer|April 24, 2020
Higher plasma asparaginase activity after intramuscular than intravenous Erwinia asparaginaseJohn C Panetta, Yiwei Liu, Hope D Swanson, et al.
Pediatric Blood & Cancer|August 30, 2020
Team approach: Management of osteonecrosis in children with acute lymphoblastic leukemiaLynne C Jones, Sue C Kaste, Seth E Karol, et al.
Pharmacotherapy|April 21, 2026
Impact of Dosing Interval Adherence on Pharmacokinetic Outcomes of Recombinant Erwinia Asparaginase in Pediatric Leukemia or LymphomaMilre M Matherne, John C Panetta, Jaclyn Hopp, et al.
Haematologica|July 18, 2020
Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone-treated miceEmily R Finch, Monique A Payton, David A Jenkins, et al.
Cancer Medicine|July 15, 2022
Vaccines against SARS-CoV-2 are safe to administer in patients with antibodies to pegaspargaseHope D Swanson, Hana Hakim, Diego R Hijano, et al.
Pediatric Blood & Cancer|December 6, 2021
Dasatinib does not exacerbate dexamethasone-induced osteonecrosis in murine models of acute lymphoblastic leukemia therapyEmily R Finch, Laura J Janke, Lie Li, et al.
Pediatric Blood & Cancer|December 31, 2016
Osteonecrosis is unrelated to hip anatomy in children with acute lymphoblastic leukemiaMary V Portera, Seth E Karol, Colton Smith, et al.
Pediatric Blood & Cancer|June 14, 2021
Effects of zoledronic acid on osteonecrosis and acute lymphoblastic leukemia treatment efficacy in preclinical modelsLaura J Janke, Jieun Kim, Monique A Payton, et al.
Pageof 9